Several animal models of heart failure, such as SHR, isolated cardiomyocytes, and transgenic models, have demonstrated that pharmacological inhibition of NHE1 can effectively prevent or induce the regression of cardiac remodeling. This evidence concerns the gene SLC9A1 and heart failure.